Matias-Guiu X - Search Results

1

Metabolomic-Based Approaches for Endometrial Cancer Diagnosis and Prognosis: A Review.

Albertí-Valls M, Megino-Luque C, Macià A, Gatius S, Matias-Guiu X, Eritja N. Albertí-Valls M, et al. Cancers (Basel). 2023 Dec 29;16(1):185. doi: 10.3390/cancers16010185. Cancers (Basel). 2023. PMID: 38201612 Free PMC article. Review.

2

CK2 controls TRAIL and Fas sensitivity by regulating FLIP levels in endometrial carcinoma cells.

Llobet D, Eritja N, Encinas M, Llecha N, Yeramian A, Pallares J, Sorolla A, Gonzalez-Tallada FJ, Matias-Guiu X, Dolcet X. Llobet D, et al. Oncogene. 2008 Apr 17;27(18):2513-24. doi: 10.1038/sj.onc.1210924. Epub 2007 Nov 5. Oncogene. 2008. PMID: 17982483

3

Antioxidants block proteasome inhibitor function in endometrial carcinoma cells.

Llobet D, Eritja N, Encinas M, Sorolla A, Yeramian A, Schoenenberger JA, Llombart-Cussac A, Marti RM, Matias-Guiu X, Dolcet X. Llobet D, et al. Anticancer Drugs. 2008 Feb;19(2):115-24. doi: 10.1097/CAD.0b013e3282f24031. Anticancer Drugs. 2008. PMID: 18176107

4

Promoter hypermethylation and reduced expression of RASSF1A are frequent molecular alterations of endometrial carcinoma.

Pallarés J, Velasco A, Eritja N, Santacana M, Dolcet X, Cuatrecasas M, Palomar-Asenjo V, Catasús L, Prat J, Matias-Guiu X. Pallarés J, et al. Mod Pathol. 2008 Jun;21(6):691-9. doi: 10.1038/modpathol.2008.38. Epub 2008 May 9. Mod Pathol. 2008. PMID: 18469797 Free article.

5

Nuclear factor-kappaB activation is associated with somatic and germ line RET mutations in medullary thyroid carcinoma.

Gallel P, Pallares J, Dolcet X, Llobet D, Eritja N, Santacana M, Yeramian A, Palomar-Asenjo V, Lagarda H, Mauricio D, Encinas M, Matias-Guiu X. Gallel P, et al. Hum Pathol. 2008 Jul;39(7):994-1001. doi: 10.1016/j.humpath.2007.11.015. Epub 2008 May 27. Hum Pathol. 2008. PMID: 18508109

6

Loss of heterozygosity in endometrial carcinoma.

Velasco A, Pallares J, Santacana M, Yeramian A, Dolcet X, Eritja N, Puente S, Sorolla A, Llecha N, Matias-Guiu X. Velasco A, et al. Int J Gynecol Pathol. 2008 Jul;27(3):305-17. doi: 10.1097/PGP.0b013e31815daf1a. Int J Gynecol Pathol. 2008. PMID: 18580307 Review.

7

Molecular pathology of endometrial carcinoma: practical aspects from the diagnostic and therapeutic viewpoints.

Llobet D, Pallares J, Yeramian A, Santacana M, Eritja N, Velasco A, Dolcet X, Matias-Guiu X. Llobet D, et al. J Clin Pathol. 2009 Sep;62(9):777-85. doi: 10.1136/jcp.2008.056101. Epub 2008 Oct 31. J Clin Pathol. 2009. PMID: 18977806 Review.

8

CK2beta is expressed in endometrial carcinoma and has a role in apoptosis resistance and cell proliferation.

Pallares J, Llobet D, Santacana M, Eritja N, Velasco A, Cuevas D, Lopez S, Palomar-Asenjo V, Yeramian A, Dolcet X, Matias-Guiu X. Pallares J, et al. Am J Pathol. 2009 Jan;174(1):287-96. doi: 10.2353/ajpath.2009.080552. Epub 2008 Dec 4. Am J Pathol. 2009. PMID: 19056846 Free PMC article.

9

A review of the applications of tissue microarray technology in understanding the molecular features of endometrial carcinoma.

Pallares J, Santacana M, Puente S, Lopez S, Yeramian A, Eritja N, Sorolla A, Llobet D, Dolcet X, Matias-Guiu X. Pallares J, et al. Anal Quant Cytol Histol. 2009 Aug;31(4):217-26. Anal Quant Cytol Histol. 2009. PMID: 19736869 Review.

10

DcR1 expression in endometrial carcinomas.

Tarragona J, Llecha N, Santacana M, Lopez S, Gatius S, Llobet D, Dolcet X, Palomar-Asenjo V, Gonzalez-Tallada FJ, Matias-Guiu X. Tarragona J, et al. Virchows Arch. 2010 Jan;456(1):39-44. doi: 10.1007/s00428-009-0855-2. Epub 2009 Nov 20. Virchows Arch. 2010. PMID: 19936781

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

517 results

Search Page

Filters